Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 111
  2. 112
  3. 113
  4. 114
  5. 115
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Ipilimumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4025B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Ipilimumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4025HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Natalizumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4037D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4025UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4029UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4030UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Name Preis
Ipilimumab Biosimilar -­ Biotin Research Grade Anmelden Ipilimumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Ipilimumab Biosimilar -­ HRP Research Grade Anmelden Ipilimumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Natalizumab Biosimilar -­ Dylight488 Research Grade Anmelden Natalizumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Ipilimumab Biosimilar -­ Ultra Low Endotoxin Anmelden Ipilimumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Pembrolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pembrolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Pertuzumab Biosimilar -­ Ultra Low Endotoxin Anmelden Pertuzumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 111
  2. 112
  3. 113
  4. 114
  5. 115
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top